Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...

Bulletin: ...FREEZE WARNING IN EFFECT FROM 11 PM THIS EVENING TO 9 AM EDT FRIDAY... * WHAT...Sub-freezing temperatures as low as the upper 20s to low 30s expected ...